GSK's RAPT Therapeutics acquisition will strengthen the former's immunology pipeline – specifically its offerings for food ...

Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.

DeepHow has launched PharmaCloud, a GMP-compliant cloud environment developed specifically to standardise AI-driven operator ...

Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...

The key element of the agreement is confirmation that UK pharmaceutical exports to the US will face a preferential tariff ...

Regene Therapeutics has received RMAT designation from the US FDA for its lead product, NouvNeu001, aimed at treating PD.

Despite a lacklustre FDI environment in British life sciences, the pharma industry could be set for a period of renaissance amid US trade agreements.

Strive Compounding Pharmacy alleges the two pharma companies are coordinating an effort to restrict compounded access.

AstraZeneca has agreed to buy AbelZeta’s 50% stake in the China development and commercialisation rights for C-CAR031.

The arrival of oral Wegovy across 70,000 US pharmacies offers a more affordable and convenient weight-loss treatment option ...

Immunocore is expanding its ImmTAX platform into autoimmune disease, outlining plans to start first‑in‑human trials of ...

Despite lacklustre dealmaking, there were still trends identified from company presentations, such as pharma's upcoming ...